Heritability of chronic obstructive pulmonary disease and related phenotypes in smokers
- PMID: 23972146
- PMCID: PMC3826281
- DOI: 10.1164/rccm.201302-0263OC
Heritability of chronic obstructive pulmonary disease and related phenotypes in smokers
Abstract
Rationale: Previous studies of chronic obstructive pulmonary disease (COPD) have suggested that genetic factors play an important role in the development of disease. However, single-nucleotide polymorphisms that are associated with COPD in genome-wide association studies have been shown to account for only a small percentage of the genetic variance in phenotypes of COPD, such as spirometry and imaging variables. These phenotypes are highly predictive of disease, and family studies have shown that spirometric phenotypes are heritable.
Objectives: To assess the heritability and coheritability of four major COPD-related phenotypes (measurements of FEV1, FEV1/FVC, percent emphysema, and percent gas trapping), and COPD affection status in smokers of non-Hispanic white and African American descent using a population design.
Methods: Single-nucleotide polymorphisms from genome-wide association studies chips were used to calculate the relatedness of pairs of individuals and a mixed model was adopted to estimate genetic variance and covariance.
Measurements and main results: In the non-Hispanic whites, estimated heritabilities of FEV1 and FEV1/FVC were both about 37%, consistent with estimates in the literature from family-based studies. For chest computed tomography scan phenotypes, estimated heritabilities were both close to 25%. Heritability of COPD affection status was estimated as 37.7% in both populations.
Conclusions: This study suggests that a large portion of the genetic risk of COPD is yet to be discovered and gives rationale for additional genetic studies of COPD. The estimates of coheritability (genetic covariance) for pairs of the phenotypes suggest considerable overlap of causal genetic loci.
Figures
Comment in
-
The future of nature versus nurture in understanding chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2013 Oct 15;188(8):891-2. doi: 10.1164/rccm.201309-1594ED. Am J Respir Crit Care Med. 2013. PMID: 24127794 No abstract available.
References
-
- Silverman EK, Chapman HA, Drazen JM, Weiss ST, Rosner B, Campbell EJ, O’Donnell WJ, Reilly JJ, Ginns L, Mentzer S, et al. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med. 1998;157:1770–1778. - PubMed
-
- Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency. Lancet. 2005;365:2225–2236. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 HL089897/HL/NHLBI NIH HHS/United States
- R01HL089856/HL/NHLBI NIH HHS/United States
- K08 HL097029/HL/NHLBI NIH HHS/United States
- U01 HL089897/HL/NHLBI NIH HHS/United States
- R01 HL089856/HL/NHLBI NIH HHS/United States
- U01 HL089856/HL/NHLBI NIH HHS/United States
- P01 HL105339/HL/NHLBI NIH HHS/United States
- U01HL089897/HL/NHLBI NIH HHS/United States
- P01HL105339/HL/NHLBI NIH HHS/United States
- U01HL089856/HL/NHLBI NIH HHS/United States
- R01HL089897/HL/NHLBI NIH HHS/United States
- K08 HL102265/HL/NHLBI NIH HHS/United States
- R01 HL113264/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
